NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH

novartis-institutes-for-biomedical-research-logo

Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis
#SimilarOrganizations #People #Financial #More

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH

Industry:
Biotechnology Medical Robotics

Status:
Active


Similar Organizations

tarsa-therapeutics-logo

Tarsa Therapeutics

Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.

Current Employees Featured

not_available_image

Elise Burmeister Getz
Elise Burmeister Getz Director, Translational Medicine @ Novartis Institutes for Biomedical Research
Director, Translational Medicine
2021-03-01

joris-van-dam_image

Joris van Dam
Joris van Dam Executive Director, Head of Digital Therapeutics @ Novartis Institutes for Biomedical Research
Executive Director, Head of Digital Therapeutics
2018-03-01

jason-laramie_image

Jason Laramie
Jason Laramie Title Vice President, Global Head Translational Medicine Data Science @ Novartis Institutes for Biomedical Research
Title Vice President, Global Head Translational Medicine Data Science
2019-04-01

ross-jones_image

Ross Jones
Ross Jones Lead of Product Excellence & Head of Product Operations @ Novartis Institutes for Biomedical Research
Lead of Product Excellence & Head of Product Operations
2021-04-01

not_available_image

Reza Mazhari
Reza Mazhari Head, Search & Evaluation, Oncology @ Novartis Institutes for Biomedical Research
Head, Search & Evaluation, Oncology
2018-07-01

ann-richardson_image

Ann Richardson
Ann Richardson CEO @ Novartis Institutes for Biomedical Research
CEO

wendi-yajnik_image

Wendi Yajnik
Wendi Yajnik Global Head of Academic Partnerships and External Innovation @ Novartis Institutes for Biomedical Research
Global Head of Academic Partnerships and External Innovation
2018-04-01

not_available_image

Elizabeth Mazsa
Elizabeth Mazsa CS&I Academy Fellow @ Novartis Institutes for Biomedical Research
CS&I Academy Fellow
2021-01-01

not_available_image

Thomas Jostock
Thomas Jostock Associate Director @ Novartis Institutes for Biomedical Research
Associate Director
2020-03-01

philip-gotwals_image

Philip Gotwals
Philip Gotwals Global Head, Business Development & Licensing @ Novartis Institutes for Biomedical Research
Global Head, Business Development & Licensing
2019-11-01

Investments List

Date Company Article Money raised
2021-02-24 Orna Therapeutics Novartis Institutes for Biomedical Research investment in Series A - Orna Therapeutics 80 M USD
2020-04-29 Cadent Therapeutics Novartis Institutes for Biomedical Research investment in Series B - Cadent Therapeutics 15 M USD
2020-03-03 Pliant Therapeutics Novartis Institutes for Biomedical Research investment in Series C - Pliant Therapeutics 100.45 M USD
2020-01-10 TScan Therapeutics Novartis Institutes for Biomedical Research investment in Series B - TScan Therapeutics 35 M USD
2019-07-24 TScan Therapeutics Novartis Institutes for Biomedical Research investment in Series B - TScan Therapeutics N/A
2019-02-14 Vor Biopharma Novartis Institutes for Biomedical Research investment in Series A - Vor Biopharma 42 M USD
2018-11-15 Cadent Therapeutics Novartis Institutes for Biomedical Research investment in Series B - Cadent Therapeutics 40 M USD
2015-01-08 Surface Oncology Novartis Institutes for Biomedical Research investment in Series A - Surface Oncology 35 M USD

More informations about "Novartis Institutes for Biomedical Research" on Search Engine

dfkcompany.com © 2022. All rights reserved